Abiopharma

🔍 Vanderjagt Katherine E. (Executive)

Company: LA-Z-BOY INC (LZB)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Acquired 6,887 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 52,155.00 | transaction_form_type: 4
• Sold 311 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 51,844.00 | transaction_form_type: 4
• Sold 484 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 51,360.00 | transaction_form_type: 4
• Acquired 4,214 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 55,574.00 | transaction_form_type: 4
• Sold 1,206 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 54,368.00 | transaction_form_type: 4
• Acquired 1,519 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 55,887.00 | transaction_form_type: 4
• Sold 435 shares of Common Shares at $39.99 per share (Direct)
  Date: 2026-06-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 55,452.00 | transaction_form_type: 4
• Acquired 1,224 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 56,676.00 | transaction_form_type: 4
• Acquired 1,318 shares of Common Shares (Direct)
  Date: 2026-06-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 57,994.00 | transaction_form_type: 4